Central molecular aspects of tricyclic antidepressant drug action.
D000241:Adenosine / Q000378:metabolism; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000097:blood / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D000242:Cyclic AMP / Q000378:metabolism; D004298:Dopamine / Q000502:physiology; D004734:Energy Metabolism; D006801:Humans; D008995:Monoamine Oxidase / Q000378:metabolism; D010275:Parasympathetic Nervous System / Q000502:physiology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D011485:Protein Binding; D014018:Tissue Distribution; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D011453:Prostaglandins; D005680:gamma-Aminobutyric Acid; D000242:Cyclic AMP; D014446:Tyrosine 3-Monooxygenase; D008995:Monoamine Oxidase; D010727:Phosphoric Diester Hydrolases; D000241:Adenosine; D004298:Dopamine